| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO
1 company
Gline Matthew is a CEO at Roivant Sciences Ltd.. Recent SEC Form 4 filings include 1 buy and 11 sells.
Estimated insider holdings value: $529.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | ROIV Roivant Sciences Ltd. | CEO | Sell | 289,774 | $29.16 | $8,449,809.84 | -1.7% | - | - | |
| Dec 15, 2025 | ROIV Roivant Sciences Ltd. | CEO | Sale+OE | 1,740,000 | $21.68 | $37,723,200.00 | -3.1% | +29.1% | - | |
| Sep 18, 2025 | ROIV Roivant Sciences Ltd. | CEO | Buy | 3,315 | $15.07 | $49,957.05 | - | +50.4% | - | |
| Sep 23, 2024 | ROIV Roivant Sciences Ltd. | CEO | Sale+OE | 1,983,257 | $11.79 | $23,382,600.03 | -10.0% | +0.6% | +23.9% | |
| Oct 25, 2022 | ROIV Roivant Sciences Ltd. | CEO | Sell | 19,276 | $4.40 | $84,814.40 | -1.6% | +77.8% | +78.7% | |
| Sep 23, 2022 | ROIV Roivant Sciences Ltd. | CEO | Sell | 21,053 | $3.07 | $64,632.71 | -1.7% | +140.8% | +245.5% | |
| Aug 24, 2022 | ROIV Roivant Sciences Ltd. | CEO | Sell | 20,009 | $3.71 | $74,233.39 | -1.6% | +29.5% | +192.4% | |
| Jul 25, 2022 | ROIV Roivant Sciences Ltd. | CEO | Sell | 20,455 | $4.33 | $88,570.15 | -1.6% | +7.0% | +157.9% | |
| Jun 23, 2022 | ROIV Roivant Sciences Ltd. | CEO | Sell | 19,855 | $4.34 | $86,170.70 | -1.6% | -31.8% | +110.3% | |
| May 20, 2022 | ROIV Roivant Sciences Ltd. | CEO | Sell | 139,791 | $3.70 | $517,226.70 | -10.0% | +3.8% | +151.9% |